Education
About Us
Working with TipRanks
Follow Us
Tenon Medical, Inc. (TNON)
NASDAQ:TNON
TNON Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.91 - $15.79
Previous CloseN/A
Volume74.29K
Average Volume (3M)13.98M
Market Cap
$15.31M
Enterprise Value$3.55M
Total Cash (Recent Filing)$245.63K
Total Debt (Recent Filing)$574.98K
Price to Earnings (P/E)―
Beta0.45
Next Earnings
Jun 10, 2025EPS Estimate
-1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.80
Shares Outstanding6,199,965
10 Day Avg. Volume36,884,953
30 Day Avg. Volume13,982,079
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.95
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.23
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda-0.27
Forecast
1Y Price Target
$3.00Price Target Upside21.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Tenon Medical, Inc. News
PremiumCompany Announcements
Tenon Medical’s Earnings Call: Cautious Optimism Amid Challenges
PremiumCompany Announcements
Tenon Medical Reports Revenue Growth and Strategic Advances
PremiumCompany Announcements
Tenon Medical’s Q3 2024 Earnings and Strategic Progress
---
Bulls Say, Bears Say
Bulls Say
Growth StrategyThe company’s focus on physician training and expanding surgeon adoption should support long-term procedural growth.
InnovationThe recent alpha launch of the Catamaran System SE expands its use cases and typifies its commitment to innovation.
Bears Say
Reimbursement ChallengesReimbursement uncertainty remains a key risk, leading to lower revenue estimates and a reduced price target.
Revenue PerformanceThe company's 3Q24 revenue was below expectations due to unforeseen reimbursement headwinds.
---
Ownership Overview
―
Insiders
0.20% Mutual Funds
1.20% Other Institutional Investors
98.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNON FAQ
What was Tenon Medical, Inc.’s price range in the past 12 months?
Tenon Medical, Inc. lowest stock price was $0.91 and its highest was $15.79 in the past 12 months.
What is Tenon Medical, Inc.’s market cap?
Tenon Medical, Inc.’s market cap is $15.31M.
When is Tenon Medical, Inc.’s upcoming earnings report date?
Tenon Medical, Inc.’s upcoming earnings report date is Jun 10, 2025 which is in 72 days.
How were Tenon Medical, Inc.’s earnings last quarter?
Tenon Medical, Inc. released its earnings results on Mar 20, 2025. The company reported $10.53 earnings per share for the quarter, beating the consensus estimate of -$3.77 by $14.3.
Is Tenon Medical, Inc. overvalued?
According to Wall Street analysts Tenon Medical, Inc.’s price is currently Undervalued.
Does Tenon Medical, Inc. pay dividends?
Tenon Medical, Inc. does not currently pay dividends.
What is Tenon Medical, Inc.’s EPS estimate?
Tenon Medical, Inc.’s EPS estimate is -1.06.
How many shares outstanding does Tenon Medical, Inc. have?
Tenon Medical, Inc. has 6,199,965 shares outstanding.
What happened to Tenon Medical, Inc.’s price movement after its last earnings report?
Tenon Medical, Inc. reported an EPS of $10.53 in its last earnings report, beating expectations of -$3.77. Following the earnings report the stock price went down -9.91%.
Which hedge fund is a major shareholder of Tenon Medical, Inc.?
Currently, no hedge funds are holding shares in TNON
---
Company Description
Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
---
TNON Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Tenon Medical demonstrated significant improvements in revenue growth and gross margin for the full year 2024, alongside promising clinical outcomes and a strong cash position. However, challenges in the fourth quarter, including a revenue decline and ongoing reimbursement issues, suggest areas needing attention. Overall, the sentiment is cautiously optimistic with a focus on future growth and overcoming current challenges.Read More>---
TNON Stock 12 Month Forecast
Average Price Target
$3.00
▲(21.46% Upside)
Technical Analysis
Best Analysts Covering TNON
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-30.26%
reiterated a buy rating 10 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -30.26% per trade.
---